Ligang Xing

4.2k total citations · 1 hit paper
132 papers, 2.7k citations indexed

About

Ligang Xing is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ligang Xing has authored 132 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 54 papers in Radiology, Nuclear Medicine and Imaging and 43 papers in Oncology. Recurrent topics in Ligang Xing's work include Lung Cancer Diagnosis and Treatment (43 papers), Radiomics and Machine Learning in Medical Imaging (36 papers) and Medical Imaging Techniques and Applications (24 papers). Ligang Xing is often cited by papers focused on Lung Cancer Diagnosis and Treatment (43 papers), Radiomics and Machine Learning in Medical Imaging (36 papers) and Medical Imaging Techniques and Applications (24 papers). Ligang Xing collaborates with scholars based in China, United States and United Kingdom. Ligang Xing's co-authors include Xiangjiao Meng, Jinming Yu, Feifei Teng, Zhaoqin Huang, Jinming Yu, Xiaorong Sun, Wanqi Zhu, Xiaorong Sun, Hanxi Zhao and Wen‐Wu Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ligang Xing

128 papers receiving 2.7k citations

Hit Papers

Predictive biomarkers in PD-1/PD-L1 checkpoint blockade i... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy
    2015 331 citations Xiangjiao Meng, Zhaoqin Huang et al. profile →

Peers

Ligang Xing
Xiangjiao Meng China
Agustin A. García United States
Aud Svindland Norway
Heather L. McArthur United States
Shunchang Jiao China
Yang Lü United States
Han Suk Ryu South Korea
Rong Tian China
Roberta Ferraldeschi United Kingdom
Xiangjiao Meng China
Ligang Xing
Citations per year, relative to Ligang Xing Ligang Xing (= 1×) peers Xiangjiao Meng

Countries citing papers authored by Ligang Xing

Since Specialization
Citations

This map shows the geographic impact of Ligang Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ligang Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligang Xing more than expected).

Fields of papers citing papers by Ligang Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ligang Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ligang Xing. The network helps show where Ligang Xing may publish in the future.

Co-authorship network of co-authors of Ligang Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Ligang Xing. A scholar is included among the top collaborators of Ligang Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ligang Xing. Ligang Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Mei, Jialin Qu, Dongxi Xiang, & Ligang Xing. (2024). Organoids in lung cancer brain metastasis: Foundational research, clinical translation, and prospective outlooks. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(1). 189235–189235. 3 indexed citations
2.
Yin, Xiaoyan, Wanqi Zhu, Guangjian Yang, et al.. (2024). Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer. BMC Cancer. 24(1). 486–486. 9 indexed citations
3.
4.
5.
Xie, Jingjing, Jia Li, Peng Xie, et al.. (2023). Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial. Scientific Reports. 13(1). 13865–13865. 15 indexed citations
6.
7.
Qiu, Qingtao, et al.. (2023). Automatic Detection of Brain Metastases in T1-Weighted Construct-Enhanced MRI Using Deep Learning Model. Cancers. 15(18). 4443–4443. 6 indexed citations
8.
Luan, Ting, et al.. (2021). A Radiomics Nomogram for Preoperative Prediction of Clinical Occult Lymph Node Metastasis in cT1-2N0M0 Solid Lung Adenocarcinoma. Cancer Management and Research. Volume 13. 8157–8167. 10 indexed citations
9.
Xing, Ligang, Yueyin Pan, Yuankai Shi, et al.. (2020). Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M–positive Non–Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study. Clinical Cancer Research. 26(23). 6168–6175. 28 indexed citations
10.
Li, Xiaoling, Ligang Xing, Yujun Zhang, et al.. (2019). Phase II Trial of Epigallocatechin-3-Gallate in Acute Radiation-Induced Esophagitis for Esophagus Cancer. Journal of Medicinal Food. 23(1). 43–49. 26 indexed citations
11.
Zhu, Wanqi, Mei Hui, Jia Li, et al.. (2019). Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial. Investigational New Drugs. 38(4). 1129–1136. 34 indexed citations
12.
Yu, Lili, et al.. (2017). Primary pancreatic lymphoma: two case reports and a literature review. OncoTargets and Therapy. Volume 10. 1687–1694. 15 indexed citations
13.
Huang, Zhaoqin, Jianbo Zhang, Haiyan Jing, et al.. (2017). Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer. Journal of Cancer. 8(16). 3190–3197. 11 indexed citations
14.
Sun, Xiaorong, Lu Sun, Peter G. Maxim, et al.. (2016). Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer. PLoS ONE. 11(6). e0157836–e0157836. 51 indexed citations
15.
Zhu, Wanqi, Jia Li, Hanxi Zhao, et al.. (2016). Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy. Oncotarget. 7(30). 48607–48613. 45 indexed citations
16.
Liu, Jing, Min Dong, Xiaorong Sun, et al.. (2016). Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS ONE. 11(1). e0146195–e0146195. 147 indexed citations
17.
Xing, Ligang, Jiandong Zhang, Peipei Wu, et al.. (2014). Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer. Journal of Cancer Research and Clinical Oncology. 140(5). 867–872. 18 indexed citations
18.
Yin, Yong, Jinhu Chen, Ligang Xing, et al.. (2011). Applications of IMAT in cervical esophageal cancer radiotherapy: a comparison with fixed‐field IMRT in dosimetry and implementation. Journal of Applied Clinical Medical Physics. 12(2). 48–57. 18 indexed citations
19.
Sun, Xindong, Dianbin Mu, Ligang Xing, et al.. (2011). Noninvasive Evaluation of Microscopic Tumor Extensions Using Standardized Uptake Value and Metabolic Tumor Volume in Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(2). 960–966. 33 indexed citations
20.
Li, Ling, Jinming Yu, Ligang Xing, et al.. (2006). Hypoxic imaging with 99mTc-HL91 single photon emission computed tomography in advanced nonsmall cell lung cancer. Chinese Medical Journal. 119(17). 1477–1480. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangjiao Meng Breakdown of academic impact, for papers by Agustin A. García Breakdown of academic impact, for papers by Aud Svindland Breakdown of academic impact, for papers by Heather L. McArthur Breakdown of academic impact, for papers by Shunchang Jiao Breakdown of academic impact, for papers by Yang Lü Breakdown of academic impact, for papers by Han Suk Ryu Breakdown of academic impact, for papers by Rong Tian Breakdown of academic impact, for papers by Roberta Ferraldeschi
Rankless by CCL
2026